1 |
Kuo JF, Andersson RG, Wise BC, Mackerlova L, Salomonsson I, Brackett NL, et al. Calcium-dependent protein kinase: widespread occurrence in various tissues and phyla of the animal kingdom and comparison of effects of phospholipid, calmodulin, and trifluoperazine. Proc Natl Acad Sci. 1980. 77: 7039-7043.
DOI
|
2 |
Laurent V, Loisel TP, Harbeck B, Wehman A, Grobe L, Jockusch BM, et al. Role of proteins of the Ena/VASP family in actin-based motility of Listeria monocytogenes. J Cell Biol. 1999. 144: 1245-1258.
DOI
|
3 |
Schwarz UR, Walter U, Eigenthaler M. Taming platelets with cyclic nucleotides. Biochem Pharmacol. 2001. 62: 1153-1161.
DOI
|
4 |
Topol EJ, Byzova TV, Plow EF. Platelet GPIIb-IIIa blockers. The Lancet. 1999. 353: 227-231.
DOI
|
5 |
Wangorsch G, Butt E, Mark R, Hubertus K, Geiger J, Dandekar T, et al. Time-resolved in silico modeling of finetuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation, BMC Syst Biol. 2011. 5: 178.
DOI
|
6 |
VargaSzabo D, Braun A, Nieswandt B. Calcium signaling in platelets. J Thromb Haemost. 2009. 7: 1057-1066.
DOI
|
7 |
Napenas J, Oost FC, DeGroot A, Loven B, Hong CH, Brennan MT, et al. Review of postoperative bleeding risk in dental patients on antiplatelet therapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013. 115: 491-499.
DOI
|
8 |
Shin JH, Kwon HW, Lee DH. Ginsenoside F4 inhibits platelet aggregation and thrombus formation by dephosphorylation of IP3RI and VASP. J Appl Biol Chem. 2019. 62: 93-100.
DOI
|
9 |
Karthika P, Rajadurai M, Ganapathy P, Kanchana G. Preventive effect of esculetin on lipid peroxides and antioxidants in isoproterenol-induced myocardial infarction in Wistar rats. J Pharm Res. 2012. 5: 915-918.
|
10 |
Liang C, Ju W, Pei S, Tang Y, Xiao Y. Pharmacological activities and synthesis of esculetin and its derivatives: A mini-review. Molecules. 2017. 22: 387.
DOI
|
11 |
Phillips DR, Nannizzi-Alaimo L, Prasad KS. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling. Thromb Haemost. 2001. 86: 246-258.
DOI
|
12 |
Quinton TM, Dean WL. Cyclic AMP-dependent phosphorylation of the inositol-1,4,5-trisphosphate receptor inhibits Ca2+ release from platelet membranes. Biochemical and Biochem Biophys Res Commun. 1992. 184: 893-899.
DOI
|
13 |
Sudo T, Ito H, Kimura Y. Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets. Platelets. 2003. 14: 381-390.
DOI
|
14 |
Farndale RW. Collagen-induced platelet activation. Blood Cell Mol Dis. 2006. 36: 162-165.
DOI
|
15 |
Cavallini L, Coassin M, Borean A, Alexandre A. Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation. J Biol Chem. 1996. 271: 5545-5551.
DOI
|
16 |
Chen H, Kahn ML. Reciprocal signaling by integrin and nonintegrin receptors during collagen activation of platelets. Mol Cell Biol. 2003. 23: 4764-4777.
DOI
|
17 |
Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985. 260: 3440-3450.
DOI
|
18 |
Hsia CW, Lin KC, Lee TY, Hsia CH, Chou DS, Jayakumar T, Velusamy M, Chang CC, Sheu JR. Esculetin, a Coumarin Derivative, Prevents Thrombosis: Inhibitory Signaling on PLCγ2-PKC-AKT Activation in Human Platelets. Int J Mol Sci. 2019. 20: 2731.
DOI
|
19 |
Kantarcioglu B, Iqbal O, Walenga JM, Lewis B, Lewis J, Carter CA, et al. An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination. Clin Appl Thromb Hemost. 2021. 27: 10760296211021498.
|
20 |
Jackson SP. Arterial thrombosis - insidious, unpredictable and deadly. Nat Med. 2011. 17: 1423-1436.
DOI
|